A B S T R A C T Isolated microvessels and isolated and cultured microvessel endothelial cells were prepared from rabbit cardiac muscle. Pathways of arachidonic acid metabolism were determined by measurement of exogenous substrate utilization ([1-'4C]arachidonic acid incorporation and release from intact tissue and cells;
INTRODUCTION
Increased attention has been focused on the role of vascular endothelium in the generation of arachidonic Received for publication 2 March 1983 and in revised form 27 July 1983. acid (AA)' metabolites. The endothelium is a major source of prostaglandin I2 (PGI2) synthesis and release (1, 2) and the PGI2 generated appears to play significant roles in the regulation of hemostasis and vascular smooth muscle contractility. The principal prostaglandin formed by the majority of large blood vessels (i.e., aorta, vena cava, etc.) is PGI2 (3) (4) (5) (6) . A few reports have suggested other enzymatic pathways of prostaglandin generation in the macrovasculature including a reduced glutathione (GSH) requiring prostaglandin H (PGH)-E isomerase in the pigeon aorta (7) and a GSH requiring PGH-D isomerase in rat blood vessels (8, 9) . The development of the methodology for the isolation of microvessels (i.e., <300 um in diameter, a mixture of arterioles, venules, and capillaries) from various tissues (10, 11) gave investigators the ability to study the nature of AA metabolism in the microvasculature. A number of studies have described the synthesis of PGI2 by cerebral microvessels (12) (13) (14) (15) (16) . However, isolated microvessels also exhibit additional pathways of prostaglandin synthesis, dependent upon the vascular bed and species examined. Isolated microvessels from the cerebral cortex of the cow (13) and cat (Gerritsen, M. E.; unpublished observations) exhibit a PGH-prostaglandin E (PGE) isomerase, while microvessels from the rat cerebral cortex exhibit a l Abbreviations used in this paper: AA, arachidonic acid; DMEM, Dulbecco's modified Eagle medium; FITC, fluorescein isothiocyanate; 15-HPETE, 15-hydroperoxyeicosatrienoic acid; HPLC, high-pressure liquid chromatography; 9-OH PGDH, 9-hydroxy-prostaglandin dehydrogenase; PGA, PGD, PGE, PGF, PGH, and PGI, prostaglandins A, D, E, F, H, and I, respectively; p-HMB, p-hydroxymercurobenzoate; PRP, platelet-rich plasma; RCME, rabbit coronary microvessel endothelial; SEM, scanning electron microscopy; TxB2, thromboxane B2.
GSH-independent prostaglandin D (PGD) synthase (14) . Microvessels from bovine cardiac muscle (11) , adrenal cortex, and retina also demonstrate GSH-dependent conversion of PGH2 to PGE2 (Gerritsen, M. E.; unpublished observations).
In the past 3 to 4 yr, rapid progress has been made in the isolation and culture of microvascular endothelial cells (17) (18) (19) (20) (21) (22) (23) (24) (25) . These studies have demonstrated that microvascular endothelial cells exhibit several fundamental differences potentially useful for the understanding and treatment of diseases with a microvascular component. Much of this information has been summarized in a recent review (26) . These studies have indicated that several features may be common to large and small blood vessel endothelium, including the presence of angiotensin-converting enzyme, Factor VIII antigen, a monolayer appearance, WeibelPalade bodies, a nonthrombogenic surface, and production of PGI2. A number of the capillary endothelial cell lines appear to require an additional matrix component (collagen, gelatin, or fibronectin) for survival and growth (17-19, 21, 27 ), a requirement not shared by endothelium derived from larger blood vessels such as the aorta and umbilical vessels. Heparin-induced migration of capillary endothelium and formation of capillary endothelial tubes have been described in adrenal capillary endothelial cell cultures (28) and may be another unique feature of microvascular endothelium.
In this study, we prepared microvessels from the rabbit heart and we isolated and cultivated microvascular endothelium from the rabbit heart. Using these preparations, we demonstrated both PGI2 synthase and PGH-PGE isomerase activities in the coronary microvascular endothelium, and we identified an additional product, most likely a metabolite of PGI2, formed by the action of 9-hydroxy-prostaglandin dehydrogenase (9-OH PGDH) on PGI2 or 6-keto-prostaglandin Fia (PGFi,). In isolated coronary microvessels and derived endothelial cells, PGE2 is synthesized and released in much greater proportions than 6-keto-PGF1,0, suggesting that PGE2 may be the major product of AA metabolism in the rabbit coronary microvasculature.
METHODS
Isolation of rabbit coronary microvessels. Procedures used for the isolation of rabbit coronary microvessels were modified from those originally described for the isolation of bovine coronary microvessels (11) . Hlearts were removed from pentobarbital anesthetized male white New Zealand rabbits, and perfused with 60 nil phosphate-buffered saline (PBS) (p11 7.4) . The atria, large coronary vessels, obvious fibrous and connective tissues, and the epi-and endocardial surfaces of the heart were removed. The remaining myocardial tissue was minced with scissors and homogenized (Sorval Omnimixer, DuPont Instruments-Sorvall Biomedical Div., Wilmington, DE) in 20 vol of PBS, pH 7.4, for four 10-s bursts at half-maximal speed. The homogenate was filtered over a 210-pnm nylon mesh sieve (Tetko Inc., Elmsford, NY) and the retentate resuspended in 20 vol of PBS and homogenized further (Sorvall Omnimixer, then four to five passes in a Dounce homogenizer, "A" pestle, Kontes Glass Co., Vineland, NJ). The resulting homogenate was filtered over a 120-tim mesh sieve and washed extensively with PBS. The retentate was removed and examined for purity by phase-contrast microscopy. The 120-iAm mesh retentate was routinely used without further purification. This preparation was virtually free of nonvascular contamination other than the presence of connective tissue that was closely associated with the microvessel networks (Fig. 1 ). Microvessels were either used immediately (e.g., [1-_4C] AA incorporation and release of radiolabeled products, immunoreactive PGE and 6-keto-PGFma release) or frozen on dry ice and stored at -70°C for later use. Homogenates were prepared from frozen preparations by powdering using a liquid N2-cooled stainless steel press, followed by homogenization of the powder in 50 mM Tris-HCl, 1 mM EDTA buffer (pH 8.1) with an all glass homogenizer (Potter-Elvehjem, Kontes Class Co.), followed by sonication in a Branson sonifier equipped with a microtip (Branson Sonic Power Co., Dansbury, CT). The resulting suspension was subjected to centrifugation (1 min at 15,000 g) and the supernatant filtered throughl glass wool. The resulting filtrate was termed the homogenate. Protein concentration was determined by a modificatioin of the Lowry method as described by Markwell and co-workers (29) , with bovine serum albumin as standard.
Isolation and cultivation of microvessel endothelial cells. The isolation procedure used was based on a modification of the method originally described by Simionescu and Simionescu (24) . Male white New Zealand rabbits ('-1 kg) were anesthetized with pentobarbital (50 mg/kg). The heart was removed and a sterile cannula introduced into the aorta. The heart was perfused with sterile 37°C PBS until blanching was observed. The atria were removed and the epicardial, subepicardial, and endocardial layers of the ventricles were cut away, as were all obvious large vessels, and connective and fibrous tissues. The remaining midportion of the myocardium was minced finely in a McIlwain tissue chopper equipped with three razor blades spaced with 0.1-mm washers. The stage was rotated 900 and the mincing repeated. The mince was incubated in Ca++-free PBS containing 1 mg/ ml collagenase (dissociation medium) and iiicubated at 37°C for 40 min with vigorous stirring. The suspension was diluted with 30 ml of Ca"+-free PBS and centrifuged for 10 min at 100 g. The supernatant was discarded and the pellet resuspended in 30 ml of dissociation medium and incubated at 37°C for an additional 30 min with gentle stirring. The resulting suspension was filtered over an 88-,um nylon mesh sieve and the filtrate homogenized in 15 ml of 37°C Ca++-free PBS in a Dounce homogenizer with the "B" pestle. This homogenate was centrifuged at 100 g for 6 min, the supernatant discarded, and the homogenization-centrifugation step repeated two additional times. The final pellet was resuspended in 12 ml of Ca++-free PBS and 6-ml fractions were layered over 4.5 ml of 6% bovine serum albumin (Sigma Chemical Co., St. Louis, MO; fraction V) in Ca"+-free PBS in 15-ml sterile centrifuge tubes, (Corning Glass Works, Corning, NY). After a 100 g centrifugation (5 min) , the resulting pellet was resuspended in Dulbecco's modified Eagles medium (DMEM) containing 20% fetal calf serum, antibiotics, antifungal agents and supplemental L-glutamine. The suspension was pipetted into Corning 35-mm plastic culture dishes, and the dishes incubated at 37°C in 5% CO2 in air. (34) . The assay is based on the transfer of [9-3H] of PGI2 to lactate by coupling the 9-OH PGDH and lactate dehydrogenase reactions. For these assays RCME and microvessel homogenates were prepared as described above, with 50 mM Tris-HCl buffer containing 1 mM EDTA and 0.1 mM dithiothreitol. The incubation mixture contained sodium pyruvate (5 nmol), NAD+ (2 nmol), lactate dehydrogenase (50 Mg), and 10,000 cpm of [9-3HJPGI2 in a total volume of 1 ml. The reaction was initiated by the addition of substrate and terminated by the addition of 300 AlI of a dextran-coated charcoal suspension (10% charcoal in 1% dextran in water), followed by centrifugation at 1,000 g for 5 min. The supernatant was decanted into scintillation vials and 10 ml PCS scintillation fluid was added, followed by scintillation counting. The observed counts per minute were converted to disintegrations per minute with a quench correction curve and external standards. Activity is expressed as picomoles of 6-keto-PGE1 formed per milligram of protein per hour.
Radioimmunoassay of PGE and 6-keto-PGF1.. The concentration of immunoreactive 6-keto-PGFIa (the stable hydrolytic product of PGI2) and immunoreactive PGE were determined in nonextracted samples of PBS that had been incubated with RCME cells or isolated coronary microvessels. Antisera were kindly supplied by Dr. Lawrence Levine (Brandeis University, Waltham, MA). The radioimmunoassay procedure was performed as detailed by Granstrom and Kindahl (35 (150%), and detectable cross-reactivity with PGE1 (25.6%), PGD2 (0.4%), PGF2,,< (0.3%), 6-keto-PGE1 (10.1%), and 15-keto-PGE2 (2.6%). The cross-reactivity with other metabolites of the AA cascade (i.e., TxB2, 6-keto-PGFI,, 13,14-dihydro-6,15-diketo-PGFi,a) and AA was <0.01%. Measurements of 6-keto-PGFi,a and PGE release from RCME cells was determined by the following protocol. Media containing fetal calf serum (FCS) were removed from confluent RCME cells. The cells were washed twice with 2 ml of warm (23°C) PBS, then incubated for 15 min at 23°C in room air in 1 ml PBS (per 17.5-mm culture well). At the end of the first incubation, the buffer was removed and 1 ml of warm PBS with or without drugs was added. The cells were incubated an additional 15 min under the above conditions, the buffer removed by aspiration, and samples from both incubations frozen on dry ice and stored at -20°C until assay.
High-pressure liquid chromatography (HPLC). Separation of PG and related compounds by HPLC was performed by a modification of the procedure originally described by van Rollins et al. (36) 
RESULTS
Isolation and identification of RCME cells Isolated rabbit coronary microvessels were prepared virtually free of nonvascular contamination, (Fig. 1) . Viable endothelial cells, as assessed by trypan blue exclusion (80-90% of the purified RCME cells excluded the dye) were harvested from the rabbit coronary microcirculation as described in Methods. Cells attached to the culture dishes within a few minutes of the initial inoculation and began to flatten out on the bottom of the dish. Removal of the medium and unattached cells 30 min after inoculation helped to select for endothelial cells. Although previous studies with capillary endothelium have reported the requirement for gelatin, collagen, or other substratum materials (19, 27) , in our hands the RCME cells attached as well to untreated culture plates. The primary cultures required high serum concentrations (15-20%) to support growth. Subsequent passages could be maintained at somewhat lower serum concentrations (10-15%). Cell division was apparent 4-8 h after addition of the isolated RCME cells to the culture dishes, and confluent monolayers were obtained in 10-20 d, dependent upon the initial plating density. Initially, cells appeared to grow out from small clusters and individual cells were elongated with a broad peripheral cytoplasm and indistinct cell borders. Near confluence, the cells exhibited a monolayer appearance and a rectangular-like shape (Fig. 2) Additional evidence for the endothelial origin of the RCME cells was provided by the presence of Factor VIII antigen and of angiotensin converting enzyme FIGURE 2 Light micrograph of a primary culture of RCME cells, near confluence. The cells exhibit a polygonal appearance with indistinct cell borders. Bar, 100 gm. (Fig. 3) . The RCME cells offered a nonthrombogenic surface to rabbit platelets; platelets were observed attaching only to regions where the underlying substrate had been exposed (Figs. 4 and 5) .
Examination of the cells by transmission electron microscopy revealed large numbers of vesicles, smooth and rough endoplasmic reticulum, fine filaments, free ribosomes, and many large structures that were apparently endoplasmic reticulum with dilated cisternae (Fig. 6 A) . When viewed in the scanning electron microscope, the cultured RCME cells appeared homogeneous. They were large cells (-20 X 60 ,um) that exhibited numerous blebs and pits apparently on the surface of the cells; these structures seemed most prominent in the perinuclear region of the cells (Fig.  6 B) . Prostaglandin synthesis and release by RCME cells and isolated rabbit coronary microvessels Incorporation and metabolism of [1-'4C]AA by intact cultured RCME cells and intact isolated microvessels. The RCME cells rapidly incorporated [1- '4C]AA into the cellular phospholipids. After a 1-h incubation 50-60% of the added [1-'4C]AA had been incorporated, predominantly into the phosphatidyl ethanolamine fraction of the phospholipids, but radioactivity was also observed co-migrating with phosphatidyl choline, phosphatidylinositol, and phosphatidylserine standards. After the 4-and 8-h incubations with [1-14C] AA, the incubation media was removed, extracted, and chromatograms developed as described in the Methods. Three major products were observed, comigrating with PGE2, 6-keto-PGFI,a, and PGF2a (Fig.   7 A) . The major product, co-migrating with authentic PGE2 was identified as PGE2 by co-migration with authentic standard in a second solvent system (ethyl ac- (Fig. 7 B) .
Additional nonpolar products of AA metabolism migrated in the regions of PGA2 (Fig. 7 C) . The synthesis of these compounds was not prevented by pretreatment of the RCME cells with indomethacin ( Fig.  7 B) , but was reduced by nordihydroguaretic acid (100 tM) pretreatment (Fig. 7 C) , suggesting that these compounds may be hydroxyacids formed by the lipoxygenase pathway.
Isolated coronary microvessels rapidly incorporated [1-'4C]AA into the phospholipid fraction, with 80-90% of the label taken up within 1 h. However, subsequent incubation of the microvessels for periods of [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] h resulted in the release of relatively (compared with the RCME cells) small amounts of labeled material comigrating with 6-keto-PGFia, PGF2,t, and PGE2. The majority of the radiolabeled material released appeared to consist of free AA and several other nonpolar compounds, probably hydroxy fatty acids (Fig. 8) . The PGE-forming activity should (a) exhibit a specific requirement for GSH as cofactor, (b) be inhibited by boiling or by pretreatment with sulfhydryl-directed reagents such as N-ethylmaleimide or p-HMB, and (c) exhibit saturation with increasing substrate (PGH2) concentrations. These criteria are based on earlier studies of PGH-PGE isomerase activity in bovine seminal vesicles (37) and bovine cerebral and coronary microvessels (11, 13) . The GSH-enhanced PGE-forming activity of the RCME cell homogenates was destroyed either by heating at 1000C for 5 min, followed by quenching on ice, or by preincubation with 5 mM p-HMB (Tables I and II) and exhibited specificity for GSH as cofactor (Table I ). In addition, the GSH-enhanced PGE-forming activity could be saturated at substrate concentrations exceeding 50 ,uM (data not shown).
A third major product comigrating with PGF2, was also observed (Fig. 9) . The position of the radiolabeled PGF2a-like compound appeared to be related to the amount of 6-keto-PGF1, formed. This was indicated at higher protein concentrations where little PGE2 was formed (in the absence of GSH), and the majority of the PGH2 was converted to 6-keto-PGFia and the PGF2a-like compound. Preincubation of the RCME cell homogenates with 15-HPETE, an inhibitor of PGI2 synthase, inhibited the formation of both 6-keto-PGFia and the PGF2a-like compound, suggesting that this unknown compound may arise from the PGI2 synthase pathway. The evidence of the lack of acid and base stability and the co-migration of the PGF2a-like compound with authentic 6-keto-PGE1 in the two solvent systems described above suggested that the unknown compound may be 6-keto-PGEI, the metabolite of PGI2 via 9-OH PGDH (34) . Additional evidence for the formation of 6-keto-PGE1 was provided by HPLC ( Fig. 10) , where radiolabeled product co-eluted with authentic 6-keto-PGE1. In Rabbit serum albumin
Homogenates equivalent to 100 ug of protein and boiled controls and rabbit serum albumin (100 gg protein) were incubated with 0. not demonstrate formation of radiolabeled material co-migrating with 6-keto-PGF1,, or PGF2a.
Homogenates prepared from rabbit coronary microvessels also demonstrated PGI2 synthase (formation of 6-keto-PGFI,a) and PGH-PGE isomerase (GSH-enhanced PGE formation) (Table II) . A variable amount of radiolabeled material also co-migrated with PGF2a, some of which could be 6-keto-PGEI. Assays of 9-OH PGDH activity indicated activities of [10] [11] [12] [13] pmol/mg protein per h, further supporting this possibility. We compared PGH2 metabolism by homogenates of rabbit coronary microvessels, freshly isolated and cultured RCME cells, circumflex coronary artery, and aorta (Table II) . GSH-enhanced PGE formation could be demonstrated in the homogenates of coronary microvessel and of isolated and cultured RCME cells, but not in homogenates of rabbit circumflex coronary artery or aorta. PGI2 synthase could be demonstrated in all of the vascular preparations. No evidence for 6- keto-PGFIa or GSH-enhanced PGE formation by control incubations with rabbit serum albumin or boiled RCME homogenates could be demonstrated (Table II) .
Release of immunoreactive 6-keto-PGFla and PGE by isolated coronary microvessels and RCME cells. Isolated coronary microvessels and cultured (primaries through sixth passage) RCME cells released detectable amounts of 6-keto-PGF1,. and PGE into the incubation buffer (PBS). Under basal conditions (i.e., in the absence of drugs), release of PGE exceeded that of 6-keto-PGFsa. Freshly isolated microvessels released 0.99±0.13 pg 6-keto-PGF1a/mg wet wt per 15 min and 10±2.31 pg PGE/mg wet wt per 15 min (n = 12). RCME cells also released more PGE than 6-keto-PGF10,, (Table 1II) . Release of both PG from the RCME cells could be increased by treatment with AA, or the calcium ionophore A 23187, melittin, and lipopolysaccharide (Table III) . We tested a second antiserum directed against PGE2 purchased from Seragen Inc. (Boston, MA). This antiserum exhibits minimal crossreactivity with PGA2. Estimates of PGE release under basal and AA-stimulated conditions with this antiserum were not significantly different from those obtained using Dr. Levine's anti-PGE antiserum, indicating that cross-reacting materials such as PGA are probably not contributing to the high PGE levels observed. Preincubation of the cells for 20 min with 5 AM indomethacin inhibited the release of 6-keto-PGF10 and PGE2 by 80-85%. We also measured the release of 6-keto-PGF10 and PGE2 from rings of rabbit circumflex coronary artery, and observed 0.24 ng 6- keto-PGFs,/mg wet wt per 15 (2) 6-keto PGE, (3) TxB2, (4) PGF2a, (5) PGE2, (6) PGD2.
lial cells derived from the rabbit myocardium. These cultures exhibit many characteristics common to endothelial cells in culture such as the production of Factor VIII antigen and other less specific endothelial markers, including angiotensin-converting enzyme, monolayer morphology, and platelet adhesion-resistant cell surface (31) .
The precise origin of the RCME cells cannot be ascertained at this time. The selection for microvascular endothelium is based on the architecture of the coronary vasculature; removal of the epicardial, subepicardial. and endocardial surfaces and large superficial vessels removes potential contamination by mesothelial cells of the epicardium and the endothelium of lymphatics, large vessels, or endocardium (24) . Although the bulk of the remaining vasculature would consist of capillaries, endothelium derived from arterioles and venules would contribute to the isolated RCME cells obtained after the isolation procedures outlined in Methods.
Prostaglandin biosynthesis by RCME cells was monitored by several procedures: endogenous release (as determined by radioimmunoassay), incorporation and metabolism of exogenous substrate ([1-'4C]AA), and enzymatic transformations of [1-'4C] PGH2 by broken cell preparations. The results demonstrate the ability of these cells to synthesize and release products derived from the PGI2 synthase (6-keto-PGFIa and possibly 6-keto-PGEI) and PGH-PGE isomerase (PGE2) pathways of PGH2 metabolism. These pathways could be demonstrated in isolated coronary microvessels, freshly isolated RCME cells, and cultured RCME cells, indicating that adaptation to growth under culture conditions did not lead to the expression of new or alternate patterns of PG production.
The generation of the compound tentatively identified as 6-keto-PGE, from PGI2 (or 6-keto-PGFI!) Recent studies by a number of investigators (38-41) have indicated that vascular smooth muscle and endothelium from several sources have the ability to synthesize both PGE2 and PGI2, and that the ratio of these products may alter when the cellular environment changes. For example, adaptation and growth of pig aorta smooth muscle and endothelial cells in culture results in an apparent loss of PGI2 synthase activity and an augmentation of PGE2 formation (39) (40) (41) . Similar alterations may occur with aging. Chang et al. (40) found that the predominant prostaglandin formed by aortic smooth muscle cells from young rats was PGI2, whereas that of older rats was PGE2. Augmentation of one pathway vs. another may be a feature of environmental adaptation in large vessel and microvascular endothelium; indeed, the synthesis and release of PGE2 may be directly related to the redox state of the endothelial cell. Furthermore, PGE synthesis may be augmented after insult, injury, or disease (42) .
Interestingly, several other investigators have reported that PGI2 is the major prostaglandin produced by the heart. As the majority of endothelium perfused in intact hearts is of the microvascular compartment, and the principal source of prostaglandins released by perfused hearts is thought to be of vascular origin (11, 43) , it is perhaps surprising that PGE2 is the primary AA metabolite synthesized by the rabbit coronary microvascular endothelium. There are several explanations for these apparent discrepancies. A < 0.05 from group 1, t test for nonpaired values, n = 6. Buffer blanks containing the drugs (e.g., A23187 and AA) used in the incubations were also analyzed by radioimmunoassay for immunoreactive 6-keto-PGFIa and PGE activity. Blank levels fell below the detection limit of the radioimmunoassay (i.e., 2 pg/tube) for all drug concentrations used. Cells used for the above study were from the first passage after primary culture.
underlines the need for careful evaluation of such investigations. DeDeckere et al. monitored release of prostanoids by a combination of biological activity profiles and gas chromatography from two components of the outflow of perfusate from the rabbit heart-that ejecting from the right ventricle (Qrv) and a small proportion escaping the interstitium and dripping from the heart (Qi). Qrv (representing material released into the circulation by the coronary macro-and microvasculature) levels of PGI2 synthase products (PGI2 and 6-keto-PGFie) were similar to those of PGE2. In contrast, Qi (representative of contributions from lymphatics, pericardium, mesothelial cells) levels of PGI2 synthase products were 16-fold that of PGE2. These observations strongly support our findings, indicating that release of PGE2 by the microvascular compartment contributes to the total venous effluent of the heart. In addition, these results indicate that studies monitoring perfusate allowed to drip over the surface of isolated heart after ejection from the right ventricle, and including that perfusate escaping the interstitium, do not accurately reflect coronary vascular PGI2 and PGE2 synthesis. A recent study by Coene et al. (47) indicated that substantial amounts of PGI2 are elaborated from the pericardium, pleural membranes, and derived mesothelial cells; thus, small amounts of adherent membranes or mesothelial cells on the surface of perfused hearts may further complicate interpretation of these studies.
It cannot be ruled out, however, that injury of the microvascular endothelium during isolation and subsequent cultivation may result in some inactivation of PGI2 synthase activity. However, the PGE2 isomerase activity was demonstrated in isolated microvessels as well as microvascular endothelium, whereas no evidence of such activity was indicated in large coronary vessels or aortae from the rabbit. PGE release from isolated coronary microvessels and microvascular endothelium exceeded that of 6-keto-PGFi,. In contrast, 6-keto-PGF10 release from the isolated circumflex coronary artery of the rabbit was greater than that of PGE2. Addition of injury-related substances such as lipopolysaccharide and melittin elicited similar increases in both 6-keto-PGFia and PGE2 from RCME cells, indicating that short-term responses to injury result in the elaboration of both prostaglandins.
It is intriguing to speculate about the function of PGI2 and PGE2 synthesis by the microvascular endothelium. Perhaps the most reasonable role is revealed by the specific biological activities of these two prostanoids. A major action of PGI2 synthesis and release would be directed at the platelet; PGI2 is a potent antiaggregatory agent, whereas PGE2 exhibits weak or opposite actions to that of PGI2 on platelet behavior (48) . Indeed, several studies have suggested in vivo influences of PGI2 on platelet aggregation in both the macro-and microcirculation (49) (50) (51) . A second major function regulated or modulated by products of the AA cascade is that of vascular reactivity. PGI2 and PGE2 can directly increase arteriolar diameter, while inhibition of PG synthesis can lead to reduced skeletal muscle vasodilitation induced by exercise or ischemia (51) (52) (53) . PGE2, but not PGI2, can reduce the vasoconstrictor response to norepinephrine in the cremaster microcirculation (54, 55) . A third action of both prostaglandins, the inhibition of norepinephrine release from sympathetic nerves (56-58) may be important in the local control of blood flow. Prostaglandins also exert other influences on the microcirculation, such as the alteration of erythrocyte deformability (59, 60) and capillary permeability (61) .
Prostaglandin Synthesis in Microvessels and Derived Endothelial Cells
In conclusion, we have demonstrated that coronary microvascular endothelium from the rabbit can be isolated and grown in primary and subsequent subculture. These endothelial cells have the ability to synthesize PGI2 and PGE2. These observations strongly suggest that a major source of the PGI2 synthase and PGH-PHE isomerase activities observed in isolated microvessel preparations is the microvascular endothelium. The microvascular endothelium also exhibits the capacity to convert a small proportion of PGI2 or 6-keto-PGFia to a compound tentatively identified as 6-keto-PGEI. The role of these AA metabolites in the physiology of the coronary microcirculation is poorly understood at this time. The isolated and cultivated RCME cells should provide a useful model for further studies concerned with the regulation of and roles of AA metabolism in the coronary microcirculation.
